ATP-sensitive
potassium (K+ATP) channel openers such as
cromakalim and
pinacidil exhibit both potent vasodilatory and anti-ischemic properties.
U-89232, a
cyanoguanidine analog of
cromakalim, has recently been found to exhibit myocardial protection during
ischemia without altering in vivo hemodynamics. We examined the effects of
U-89232,
cromakalim and
pinacidil in isolated vascular and cardiac tissue and tested whether
glyburide, a
KATP channel blocker, could antagonize their effects. All three compounds produced concentration-dependent relaxation in isolated vascular segments, with
cromakalim being approximately 100-fold more potent than either
pinacidil or
U-89232.
Glyburide completely antagonized the effects of
pinacidil but merely blunted the effects of
cromakalim and
U-89232. In an isolated rabbit cardiac tissue preparation,
U-89232 had little effect on maximum tension in cardiac muscle, whereas
cromakalim and
pinacidil significantly decreased maximum developed tension in a concentration-dependent manner.
Glyburide effectively antagonized the effects of
cromakalim and
pinacidil in cardiac tissue. These data suggest that
U-89232, although chemically related to
cromakalim, possesses activity which is not common to known
potassium channel openers.